The Romanian pharmaceutical market posted a 16.9% growth in thefirst 11 months of 2010, to 9.3 billion RON (2.2 billion euros),according to data of IMS Health research company.
In terms of volume, the increase amounted to just 1.6%, whichindicates a rise in the weighted mean price. On the one hand, theHealth Ministry has approved an increase in the price of drugs byaround 6% and on the other hand, the share of expensive drugsincreased on the market, after producers focused on sellinghigher-priced drugs.
December will most likely fail to influence the marketsignificantly, with 2010 figures in the drug industry to reveal anaround 17% increase. In fact, the market exceeded forecasts of themain players, who were more pessimistic and expected an increase ofa maximum of 10% in value in RON and a decline in euros.
Pentru alte știri, analize, articole și informații din business în timp real urmărește Ziarul Financiar pe WhatsApp Channels
